bullish
JD Health: Framing the Valuation Discussion
395 Views17 Nov 2020 10:07
This Insight discusses the assumptions required to justify JD Health's reportedly target valuation of US$20 billion with a buildup by each business segment.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
Price Chart(Sign Up to Access)
- JD Health (京东健康) IPO - Ali Health 1H Results Read Through and Index Inclusions27 Nov 2020
- Asian Healthcare - Coming of Age26 Nov 2020
- JD Health (京东健康) IPO - Paying to Ride the Early Innings of Healthcare Transformation25 Nov 2020
- JD Health (京东健康) Pre-IPO - Updates from PHIP - Fine-Tuning Forecasts16 Nov 2020
- JD Health: Examining the Infant16 Nov 2020
- JD Health: Looking Beyond the Obvious01 Nov 2020
x